Plain-English translation of NCT07610239 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new mobile app system designed to screen newborns and young infants for sickle cell disease in Uganda. The app captures test results at the point of care, interprets them right away, and sends the information to both local health providers and the national health system. This new system is being compared to the traditional way screening is currently done, to see if it helps more babies get tested and receive care faster.
Sickle cell disease can cause serious health problems and death in young children if not caught early, but many babies in Uganda don't get screened or don't receive follow-up care after screening. This trial exists to see if this mobile app system can make screening faster, easier, and more connected so that more children are diagnosed and treated before complications develop.
You likely qualify if…
You likely don't qualify if…
If your health center is selected for the study, you and your baby may receive sickle cell screening using the new mobile app system, which takes a small blood sample and gives results on the spot. The app will also store educational videos to help you understand the screening and any results. Your baby's health information will be recorded in the app and shared securely with the national health system so providers can follow your child's care over time. The study will track how well the new system works compared to the old way of screening.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Uganda